Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Barriere

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Drug Intelligence & Clinical Pharmacy|July 1, 1986
Prevention and management of enterococcal infection: cost implicationsS L Barriere
The American Journal of Medicine|April 27, 1987
Economic impact of oral ciprofloxacin. A pharmacist's perspectiveS L Barriere
Clinical Pharmacy|July 1, 1988
Infectious complications of AIDSS L Barriere
Pharmacotherapy|January 1, 1992
Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapyS L Barriere
Pharmacotherapy|January 1, 1990
Pharmacology and pharmacokinetics of traditional systemic antifungal agentsS L Barriere
Clinical Pharmacy|January 1, 1984
"Long-acting" cephalosporins: cost effective but efficacy questionableS L Barriere
The Annals of Pharmacotherapy|September 1, 1993
Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporinS L Barriere
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1992
Pharmacology and pharmacokinetics of cefprozilS L Barriere
American Journal of Hospital Pharmacy|March 1, 1986
Cost-effective antimicrobial therapyS L Barriere
Clinical Pharmacy|September 1, 1983
Proper use of vancomycinS L Barriere
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Drug Intelligence & Clinical Pharmacy|July 1, 1986
Prevention and management of enterococcal infection: cost implicationsS L Barriere
The American Journal of Medicine|April 27, 1987
Economic impact of oral ciprofloxacin. A pharmacist's perspectiveS L Barriere
Clinical Pharmacy|July 1, 1988
Infectious complications of AIDSS L Barriere
Pharmacotherapy|January 1, 1992
Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapyS L Barriere
Pharmacotherapy|January 1, 1990
Pharmacology and pharmacokinetics of traditional systemic antifungal agentsS L Barriere
Clinical Pharmacy|January 1, 1984
"Long-acting" cephalosporins: cost effective but efficacy questionableS L Barriere
The Annals of Pharmacotherapy|September 1, 1993
Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporinS L Barriere
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1992
Pharmacology and pharmacokinetics of cefprozilS L Barriere
American Journal of Hospital Pharmacy|March 1, 1986
Cost-effective antimicrobial therapyS L Barriere
Clinical Pharmacy|September 1, 1983
Proper use of vancomycinS L Barriere
Pageof 10